Table 1. The predicted HLA-A2 binding peptides derived from the prostate-specific G-protein coupled receptor (PSGR).

Peptide #	HLA restriction	Position	Sequence
PSGR1	HLA-A2	287–295	VLNPIVYGV
PSGR2	HLA-A2	188–196	KLACDDIRV
PSGR3	HLA-A2	276–284	ILANIYLLV
PSGR4	HLA-A2	28–36	WLAFPLCSL
PSGR5	HLA-A2	220–228	YLLILKTVL
PSGR7	HLA-A2	181–189	CLHQDVMKL
PSGR10	HLA-A2	213–222	SLLISFSYLL
PSGR11	HLA-A2	245–254	HVCAVFIFYV
PSGR12	HLA-A2	21–30	GLEEAQFWLA
PSGR13	HLA-A2	156–165	ALMAPLPVFI
PSGR14	HLA-A2	275–284	VILANIYLLV
PSGR15	HLA-A2	221–230	LLILKTVLGL
PSGR16	HLA-A2	37–46	YLIAVLGNLT
PSGR17	HLA-A2	66–75	CMLSGIDILI
PSGR18	HLA-A2	100–109	LLQMFAIHSL
PSGR19	HLA-A2	56–65	SLHEPMYIFL
PSGR20	HLA-A2	117–126	LLAMAFDRYV
PSGR21	HLA-A2	41–50	VLGNLTIIYI
PSGR22	HLA-A2	250–259	FIFYVPFIGL
PSGR23	HLA-A2	139–148	TLPRVTKIGV
PSGR24	HLA-A2	253–262	YVPFIGLSMV